Kerry Fisher
- Genetics top 2%
- Virus-based gene therapy research 22
- Oncology top 5%
- CAR-T cell therapy research 12
- Biotechnology top 5%
- Cancer Research and Treatments 11
- Virology top 10%
- Immunology top 10%
- Immunotherapy and Immune Responses 2
-
- RNA Interference and Gene Delivery 8
- Viral Infectious Diseases and Gene Expression in Insects 6
- Advanced biosensing and bioanalysis techniques 2
-
- Nanopore and Nanochannel Transport Studies 2
- Co-authors
- Leonard W. SeymourAhmet HaziniKarel UlbrichVladimír ŠubrBrian ChampionRobert CarlisleAndré LieberKent L. Richards
- Cited by
- GeneticsOncologyBiotechnology
- Journals
- Journal of Clinical Oncology (4 papers)Journal for ImmunoTherapy of Cancer (3 papers)Human Gene Therapy (2 papers)
- Partner nations
- United KingdomUnited StatesSpain
In The Last Decade
Kerry Fisher
28 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 70
- Genetics 748
- Oncology 606
- Biotechnology 142
- Virology 77
- Immunology 271
Countries citing papers authored by Kerry Fisher
This map shows the geographic impact of Kerry Fisher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kerry Fisher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kerry Fisher more than expected).
Fields of papers citing papers by Kerry Fisher
This network shows the impact of papers produced by Kerry Fisher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kerry Fisher. The network helps show where Kerry Fisher may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kerry Fisher, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2021 | 13 | |
| 3 | 2021 | 121 | |
| 4 | 2020 | 9 | |
| 5 | 2020 | 35 | |
| 6 | 2020 | 18 | |
| 7 | 2019 | 64 | |
| 8 | 2019 | 72 | |
| 9 | 2018 | 135 | |
| 10 | 2017 | 24 | |
| 11 | 2016 | 3 | |
| 12 | 2014 | 5 | |
| 13 | 2011 | 10 | |
| 14 | 2009 | 119 | |
| 15 | 2009 | 4 | |
| 16 | Establishment of a positive-readout reporter system for siRNAs. | 2009 | 4 |
| 17 | 2008 | 53 | |
| 18 | 2008 | 153 | |
| 19 | 2008 | 43 | |
| 20 | 2000 | 129 |
About Kerry Fisher
Kerry Fisher is a scholar working on Biotechnology, Genetics and Oncology, having authored 28 papers that have together received 1.3k indexed citations. Recurring topics across this work include Virus-based gene therapy research (22 papers), CAR-T cell therapy research (12 papers), Cancer Research and Treatments (11 papers), RNA Interference and Gene Delivery (8 papers), Viral Infectious Diseases and Gene Expression in Insects (6 papers), Immunotherapy and Immune Responses (2 papers), Nanopore and Nanochannel Transport Studies (2 papers) and Advanced biosensing and bioanalysis techniques (2 papers). The work is most often cited by research in Genetics (748 citations), Oncology (606 citations) and Biotechnology (142 citations). Kerry Fisher has collaborated with scholars based in United Kingdom, United States and Spain. Frequent co-authors include Leonard W. Seymour, Ahmet Hazini, Karel Ulbrich, Vladimír Šubr, Brian Champion, Robert Carlisle, André Lieber, Kent L. Richards, Jean P. Flores and Joshua D. Freedman. Their work appears in journals such as Journal of Clinical Oncology, Journal for ImmunoTherapy of Cancer, Human Gene Therapy, Molecular Therapy — Oncolytics and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.